MELAS | MT-TL1, MT-ND5, MTTQ, MTTH, MTTK, MTTS1, MTND1, MTND5, MTND6, MTTS2 | The cardinal feature of MELAS is recurrent stroke-like episodes with resultant transient hemiparesis, hemianopsia, or cortical blindness. Repeated stroke-like episodes lead to impairment of cognitive, motor, and visual abilities. Seizures, recurrent headaches, exercise intolerance, weakness, and sensorineural hearing loss are commonly seen. |
MERRF | MTTK, MTTL1, MTTH, MTTS1, MTTS2, MTTF, MTND5 | MERRF is characterized by myoclonic seizures, proximal myopathy, ataxia, and cognitive decline. Other common findings include cardiomyopathy, Wolff-Parkinson-White (WPW) syndrome, optic atrophy, hearing loss, and short stature. Multiple symmetrical lipomatosis (Madelung disease) has been described in some patients. |
NARP | MTATP6 | The cardinal features of NARP are sensory motor neuropathy, cerebellar ataxia, and retinitis pigmentosa. Other common findings include dementia, seizures, proximal muscle weakness, and hearing loss. Usually there is no histologic evidence of mitochondrial myopathy. |
LHON | MTND1, MTND4, MTND6 | LHON is characterized by bilateral painless visual loss and usually presents in young adults. Males are approximately four times more likely to be affected. Other features include cardiac arrhythmias, myopathy, peripheral neuropathy, dystonia and WPW syndrome. A minority of female LHON carriers develop clinical and neuroimaging features indistinguishable from multiple sclerosis. |